ANTIVERT

LOE Approaching

meclizine hydrochloride

R-Pharm US
NDAORALTABLET
Approved
Feb 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

H1 receptor.

Indications (1)

vertigo associated with diseases affecting the vestibular system in adults
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers